MediPharm Labs Achieves Major Pharmaceutical Manufacturing Milestone: Receives Canadian GMP Pharmaceutical Drug Establishment Licence

Health Canada Drug Establishment Licence allows MediPharm Labs to conduct pharmaceutical manufacturing and sale of Active Pharmaceutical Ingredients and Pharmaceutical

Read more

Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc

DUBLIN, May 5, 2021 /PRNewswire/ — Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced the completion of its acquisition of GW Pharmaceuticals plc (Nasdaq: GWPH) (“GW”), a

Read more

GW Pharmaceuticals Provides Preliminary Fourth Quarter and Full-Year 2020 Net Product Sales Results and 2021 Program Milestones

 Total preliminary net product sales of approximately $148 million for the fourth quarter and approximately $526 million for the full

Read more

GW Pharmaceuticals plc Reports Third Quarter 2020 Financial Results and Operational Progress

– Total revenue increased 51 percent to $137.1 million – – Epidiolex for seizures associated with TSC launched in the U.S. –– Nabiximols Phase 3 program in MS spasticity now recruiting –– Conference call today

Read more

Perrigo Partners With Kazmira LLC To Enter CBD Market Through A Two-Phased, Science-Based Approach

DUBLIN, June 17, 2020 /PRNewswire/ — Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of Quality, Affordable Self-Care Products, announced today

Read more